Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Quarterly results

Kindred Biosciences, Inc. (KIN) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/13/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/30/2021 4 Chin Richard (CEO) has filed a Form 4 on Kindred Biosciences, Inc.
Txns: Disposed/sold 1,709,271 shares @ $9.25, valued at $15.8M
Disposed/sold 2,000 shares @ $9.25, valued at $18.5k
Disposed/sold 400,000 options to buy @ $0.36, valued at $144k
Disposed/sold 350,000 options to buy @ $16.52, valued at $5.8M
Disposed/sold 197,771 options to buy @ $6.46, valued at $1.3M
Disposed/sold 197,771 options to buy @ $3.45, valued at $682.3k
Disposed/sold 175,000 options to buy @ $6.4, valued at $1.1M
Disposed/sold 175,000 options to buy @ $8.75, valued at $1.5M
Disposed/sold 400,000 options to buy @ $9.91, valued at $4M
Disposed/sold 300,000 options to buy @ $9.84, valued at $3M
Disposed/sold 394,000 options to buy @ $4.44, valued at $1.7M
08/30/2021 4 Wee Wendy (CFO) has filed a Form 4 on Kindred Biosciences, Inc.
Txns: Disposed/sold 78,613 shares @ $9.25, valued at $727.2k
Disposed/sold 32,500 options to buy @ $6.96, valued at $226.2k
Disposed/sold 10,000 options to buy @ $3.25, valued at $32.5k
Disposed/sold 75,000 options to buy @ $6.4, valued at $480k
Disposed/sold 50,000 options to buy @ $7.1, valued at $355k
Disposed/sold 75,000 options to buy @ $8.75, valued at $656.3k
Disposed/sold 100,000 options to buy @ $9.91, valued at $991k
Disposed/sold 50,000 options to buy @ $9.84, valued at $492k
Disposed/sold 83,500 options to buy @ $4.44, valued at $370.7k
08/30/2021 4 Bevers Denise (Director) has filed a Form 4 on Kindred Biosciences, Inc.
Txns: Disposed/sold 145,835 shares @ $9.25, valued at $1.3M
Disposed/sold 20,400 options to buy @ $0.9, valued at $18.4k
Disposed/sold 96,092 options to buy @ $1.37, valued at $131.6k
Disposed/sold 75,000 options to buy @ $15.41, valued at $1.2M
Disposed/sold 59,031 options to buy @ $6.96, valued at $410.9k
Disposed/sold 59,031 options to buy @ $3.45, valued at $203.7k
Disposed/sold 30,000 options to buy @ $3.6, valued at $108k
Disposed/sold 100,000 options to buy @ $6.4, valued at $640k
Disposed/sold 100,000 options to buy @ $8.75, valued at $875k
Disposed/sold 75,000 options to buy @ $12.6, valued at $945k
Disposed/sold 150,000 options to buy @ $9.91, valued at $1.5M
08/30/2021 4 Zhan Hangjun (Chief Scientific Officer) has filed a Form 4 on Kindred Biosciences, Inc.
Txns: Disposed/sold 64,306 shares @ $9.25, valued at $594.8k
Disposed/sold 12,000 options to buy @ $19.96, valued at $239.5k
Disposed/sold 7,500 options to buy @ $9.17, valued at $68.8k
Disposed/sold 8,000 options to buy @ $6.96, valued at $55.7k
Disposed/sold 10,000 options to buy @ $3.25, valued at $32.5k
Disposed/sold 15,000 options to buy @ $3.6, valued at $54k
Disposed/sold 75,000 options to buy @ $6.4, valued at $480k
Disposed/sold 50,000 options to buy @ $7.65, valued at $382.5k
Disposed/sold 80,000 options to buy @ $8.75, valued at $700k
Disposed/sold 100,000 options to buy @ $9.91, valued at $991k
Disposed/sold 50,000 options to buy @ $9.84, valued at $492k
08/30/2021 4 Veszpremi Ervin (Director) has filed a Form 4 on Kindred Biosciences, Inc.
Txns: Disposed/sold 40,000 options to buy @ $0.32, valued at $12.8k
Disposed/sold 20,000 options to buy @ $1.37, valued at $27.4k
Disposed/sold 35,000 options to buy @ $15.41, valued at $539.4k
Disposed/sold 44,000 options to buy @ $6.96, valued at $306.2k
Disposed/sold 44,000 options to buy @ $3.45, valued at $151.8k
Disposed/sold 49,900 options to buy @ $6.4, valued at $319.4k
Disposed/sold 75,000 options to buy @ $8.75, valued at $656.3k
Disposed/sold 50,000 options to buy @ $9.91, valued at $495.5k
Disposed/sold 50,000 options to buy @ $9.84, valued at $492k
Disposed/sold 50,000 options to buy @ $4.44, valued at $222k
08/30/2021 4 Townsend Raymond (Director) has filed a Form 4 on Kindred Biosciences, Inc.
Txns: Disposed/sold 24,928 shares @ $9.25, valued at $230.6k
Disposed/sold 20,000 options to buy @ $7, valued at $140k
Disposed/sold 34,000 options to buy @ $15.41, valued at $523.9k
Disposed/sold 44,000 options to buy @ $6.96, valued at $306.2k
Disposed/sold 18,892 options to buy @ $3.45, valued at $65.2k
Disposed/sold 49,900 options to buy @ $6.4, valued at $319.4k
Disposed/sold 75,000 options to buy @ $8.75, valued at $656.3k
Disposed/sold 50,000 options to buy @ $9.91, valued at $495.5k
Disposed/sold 50,000 options to buy @ $9.84, valued at $492k
Disposed/sold 50,000 options to buy @ $4.44, valued at $222k
08/30/2021 4 MONTGOMERY HERBERT D (Director) has filed a Form 4 on Kindred Biosciences, Inc.
Txns: Disposed/sold 27,500 options to buy @ $3.52, valued at $96.8k
Disposed/sold 3,350 options to buy @ $4.14, valued at $13.9k
Disposed/sold 49,900 options to buy @ $6.4, valued at $319.4k
Disposed/sold 75,000 options to buy @ $8.75, valued at $656.3k
Disposed/sold 51,500 options to buy @ $9.91, valued at $510.4k
Disposed/sold 51,500 options to buy @ $9.84, valued at $506.8k
Disposed/sold 51,500 options to buy @ $4.44, valued at $228.7k
08/30/2021 4 McCracken Joseph S (Director) has filed a Form 4 on Kindred Biosciences, Inc.
Txns: Disposed/sold 41,890 options to buy @ $9.65, valued at $404.2k
Disposed/sold 10,000 options to buy @ $11, valued at $110k
Disposed/sold 48,500 options to buy @ $9.91, valued at $480.6k
Disposed/sold 48,500 options to buy @ $9.84, valued at $477.2k
Disposed/sold 48,500 options to buy @ $4.44, valued at $215.3k
08/30/2021 4 Lien Lyndon (Director) has filed a Form 4 on Kindred Biosciences, Inc.
Txns: Disposed/sold 47,000 options to buy @ $5.08, valued at $238.8k
08/30/2021 4 Liu Nanxi (Director) has filed a Form 4 on Kindred Biosciences, Inc.
Txns: Disposed/sold 48,000 options to buy @ $5.08, valued at $243.8k
08/30/2021 4 Elanco Animal Health Inc (10% Owner) has filed a Form 4 on Kindred Biosciences, Inc.
Txns: Bought 45,508,938 shares @ $9.25, valued at $421M
08/04/2021 4 Chin Richard (CEO) has filed a Form 4 on Kindred Biosciences, Inc.
Txns: Gifted 320,000 shares @ $0
Sold 40,000 shares @ $9.206, valued at $368.2k
07/07/2021 4 Chin Richard (CEO) has filed a Form 4 on Kindred Biosciences, Inc.
Txns: Sold 40,000 shares @ $9.177, valued at $367.1k
06/17/2021 4 Chin Richard (CEO) has filed a Form 4 on Kindred Biosciences, Inc.
Txns: Sold 40,000 shares @ $9.1817, valued at $367.3k
06/07/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/18/2021 4 Bevers Denise (Director) has filed a Form 4 on Kindred Biosciences, Inc.
Txns: Sold 8,396 shares @ $5.002, valued at $42k
Exercised 8,396 options to buy @ $0.32, valued at $2.7k
02/23/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/09/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/09/2021 4 Liu Nanxi (Director) has filed a Form 4 on Kindred Biosciences, Inc.
Txns: Granted 48,000 options to buy @ $5.08, valued at $243.8k
02/03/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/01/2021 4 Park West Asset Management LLC (10% Owner) has filed a Form 4 on Kindred Biosciences, Inc.
Txns: Sold 210,472 shares @ $5.25, valued at $1.1M
Sold 3,300 shares @ $5.07, valued at $16.7k
01/26/2021 4 Wee Wendy (CFO) has filed a Form 4 on Kindred Biosciences, Inc.
Txns: Paid exercise price by delivering 4,062 shares @ $4.93, valued at $20k
Paid exercise price by delivering 3,385 shares @ $4.93, valued at $16.7k
Exercised 7,500 restricted stock units @ $0
01/26/2021 4 Zhan Hangjun (Chief Scientific Officer) has filed a Form 4 on Kindred Biosciences, Inc.
Txns: Paid exercise price by delivering 3,385 shares @ $4.93, valued at $16.7k
Paid exercise price by delivering 3,385 shares @ $4.93, valued at $16.7k
Exercised 6,250 restricted stock units @ $0
01/26/2021 4 Chin Richard (CEO) has filed a Form 4 on Kindred Biosciences, Inc.
Txns: Paid exercise price by delivering 19,744 shares @ $4.93, valued at $97.3k
Paid exercise price by delivering 13,163 shares @ $4.93, valued at $64.9k
Exercised 37,500 restricted stock units @ $0
01/22/2021 4 Veszpremi Ervin (Director) has filed a Form 4 on Kindred Biosciences, Inc.
Txns: Granted 50,000 options to buy @ $4.44, valued at $222k
01/22/2021 4 McCracken Joseph S (Director) has filed a Form 4 on Kindred Biosciences, Inc.
Txns: Granted 48,500 options to buy @ $4.44, valued at $215.3k
01/22/2021 4 MARIO ERNEST (Director) has filed a Form 4 on Kindred Biosciences, Inc.
Txns: Granted 49,000 options to buy @ $4.44, valued at $217.6k
01/22/2021 4 Townsend Raymond (Director) has filed a Form 4 on Kindred Biosciences, Inc.
Txns: Granted 50,000 options to buy @ $4.44, valued at $222k
01/22/2021 4 MONTGOMERY HERBERT D (Director) has filed a Form 4 on Kindred Biosciences, Inc.
Txns: Granted 51,500 options to buy @ $4.44, valued at $228.7k
01/22/2021 4 Bevers Denise (Director) has filed a Form 4 on Kindred Biosciences, Inc.
Txns: Granted 46,000 options to buy @ $4.44, valued at $204.2k
01/20/2021 4 Chin Richard (CEO) has filed a Form 4 on Kindred Biosciences, Inc.
Txns: Paid exercise price by delivering 21,128 shares @ $4.95, valued at $104.6k
Exercised 37,500 restricted stock units @ $0
Granted 394,000 options to buy @ $4.44, valued at $1.7M
01/20/2021 4 Wee Wendy (CFO) has filed a Form 4 on Kindred Biosciences, Inc.
Txns: Paid exercise price by delivering 3,385 shares @ $4.95, valued at $16.8k
Exercised 6,250 restricted stock units @ $0
Granted 83,500 options to buy @ $4.44, valued at $370.7k
01/20/2021 4 Zhan Hangjun (Chief Scientific Officer) has filed a Form 4 on Kindred Biosciences, Inc.
Txns: Paid exercise price by delivering 3,385 shares @ $4.95, valued at $16.8k
Exercised 6,250 restricted stock units @ $0
Granted 83,500 options to buy @ $4.44, valued at $370.7k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy